Sugammadex and cholinesterase inhibitors.
de Boer
H D
HD
D000732:Androstanols / Q000037:antagonists & inhibitors; D001285:Atropine / Q000008:administration & dosage / Q000009:adverse effects; D002800:Cholinesterase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009388:Neostigmine / Q000008:administration & dosage / Q000009:adverse effects; D019148:Neuromuscular Blockade / Q000009:adverse effects / Q000379:methods*; D000077123:Rocuronium; D000077122:Sugammadex; D047408:gamma-Cyclodextrins / Q000008:administration & dosage* / Q000009:adverse effects
D000732:Androstanols; D002800:Cholinesterase Inhibitors; D047408:gamma-Cyclodextrins; D000077122:Sugammadex; D009388:Neostigmine; D001285:Atropine; D000077123:Rocuronium